Trial intelligence / Profile preview

PIV vs ESP for Bleeding and Pain Control in Lumbar Arthrodesis

2025-521572-56-00Phase 3Authorised

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Aug 2025
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of tranexamic acid and epinephrine in postoperative pain and Not applicable (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Intraoperative bleeding. Planned start Aug 2025; status: authorised.

02

Drugs

tranexamic acidepinephrine
03

Conditions

postoperative painNot applicable

Beyond the preview

Go deeper on 2025-521572-56-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-521572-56-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call